TransMedics Group Inc (NAS:TMDX)
$ 59.853 -1.167 (-1.91%) Market Cap: 2.01 Bil Enterprise Value: 2.24 Bil PE Ratio: 63.67 PB Ratio: 9.56 GF Score: 70/100

Transmedics Group Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 12:40PM GMT
Release Date Price: $59.53 (+1.64%)
Patrick Andrew Robert Wood
Morgan Stanley, Research Division - Former Research Analyst

Thank you, everybody, for joining us. Patrick Wood, I run the U.S. med tech team here. I get an exciting disclosure to you before we start, which is, please see Morgan Stanley Research disclosures website, morganstanley.com, research disclosures. I'm sure all of you will be going there. Any questions, feel free to reach out to your sales rep. And with that, very excited to have Waleed Hassanein and Stephen Gordon, CEO and CFO of TransMedics, respectively, for what should be a really fun discussion for outside chat. I'm sure you're all familiar with TransMedics. And for those of you who on, it's a super interesting story.

Questions & Answers

Patrick Andrew Robert Wood
Morgan Stanley, Research Division - Former Research Analyst

And so maybe if we kick it off, I think the 2023 guidance and '24, it implies a slight slowdown in the second half of the year. I mean is it realistic to say that some of that's maybe a little bit of conservatism or are you seeing something

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot